Amblyopia Market Size Worth USD 6.25 Billion by 2030 | MRFR

Major Companies Cover Analyzed in the Amblyopia Market Research Study:

• Generation Health, LLC


• Pfizer, Inc.


• Pixium Vision


• DigiSight


• Essilor International SA


• Novartis AG


• Allergan, Inc.


• Novartis Pharmaceuticals Corporation


• Omeros Corporation


• Alimera Sciences, Inc.


• AcuFocus, Inc.


• ReNeuron Group Plc

Market Segmentation

MRFR’s report provides a segmental review of the global amblyopia market for a better understanding of the market. The market is segmented based on treatment, type, and region.

By treatment, the amblyopia market is segmented into artificial intelligence, visual therapy, eye patch, and surgery. Of these, the visual therapy segment is likely to acquire the largest market share in the coming years, as this is the most efficient and economical option to treat amblyopia in humans.

By type, the amblyopia market can be segmented into strabismic amblyopia, refractive amblyopia, and deprivational amblyopia. Of these, the refractive amblyopia segment has acquired the largest market share so far and is likely to remain the most important segment over the next few years.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Amblyopia Market Research Report

Regional Analysis

The study by MRFR examines the regional segmentation of the amblyopia market in in detail. The market is comprised of North America, Europe, Asia-Pacific, and Rest of The World (RoW) as its primary geographical segments.

North America holds the largest market share for amblyopia and is likely to grow at an impressive rate in the coming years. The growing expenditure in the healthcare sector and the increasing prevalence of eye defects in the region, along with the number of treatments provided, are likely to boost the regional market.

Europe comes in second in the global amblyopia market size, with the developments in the healthcare sector boosting the market significantly. The increasing prevalence of eye defects and the demand for advanced and efficient treatments are likely to drive the regional market.

The Asia-Pacific market is a formidable competitor for the global amblyopia market share and is anticipated to expand at a rapid rate over the forecast period. This is attributable to the rising population in a number of countries in the region, as well as the growing awareness of eye health.

Market Forecast

MRFR’s report has offered an 8-year market forecast for the amblyopia market on the basis of the market performance in the last two years. This provides a clearer understanding of the current market trend and its likely future developments.

Competitive Analysis

The global amblyopia market is a highly competitive market with a number of players operating in it. Several manufacturers and research institutes are undertaking strategic activities to stay ahead of the competition. These players are focusing on activities such as product innovations, mergers and acquisitions, and strategic collaborations to remain at the forefront of amblyopia market.

Generation Health, LLC, pfizer, Inc., Pixium Vision, DigiSight, Essilor International SA, Novartis AG, Allergan, Inc., Novartis Pharmaceuticals Corporation, Omeros Corporation, Alimera Sciences, Inc., AcuFocus, Inc., and ReNeuron Group Plc. are some of the major players operating in the global amblyopia market.